Intervention Protocol

Risperidone for disruptive behaviour disorders in children with intellectual disabilities

  1. Heidre Bezuidenhout1,*,
  2. Charles Shey Wiysonge2,
  3. Judith M Bentley3

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 11 JUL 2012

DOI: 10.1002/14651858.CD009988


How to Cite

Bezuidenhout H, Wiysonge CS, Bentley JM. Risperidone for disruptive behaviour disorders in children with intellectual disabilities (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD009988. DOI: 10.1002/14651858.CD009988.

Author Information

  1. 1

    Red Cross Hospital, University of Cape Town, Western Cape Provincial Administration, Cape Town, Western, South Africa

  2. 2

    University of Cape Town, Institute of Infectious Disease and Molecular Medicine & Division of Medical Microbiology, Observatory, South Africa

  3. 3

    University of Cape Town, Department of Psychiatry and Mental Health, Cape Town, Western Cape, South Africa

*Heidre Bezuidenhout, Western Cape Provincial Administration, Red Cross Hospital, University of Cape Town, 201 Bayviews, Clifford Road, Seapoint, Cape Town, Western, 8500, South Africa. heidreb@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 11 JUL 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of risperidone for disruptive behaviour disorders in children and adolescents with intellectual disability.